579 results on '"Ranson, M."'
Search Results
2. Quasi-experimental study designs series–paper 12: strengthening global capacity for evidence synthesis of quasi-experimental health systems research
3. Quality of Hysterectomy Care in Rural Gujarat: The Role of Community-Based Health Insurance
4. 841 Metabolic reprogramming by cancer-associated mutant OXA1L promotes tumor progression and dedifferentiation
5. 842 Extrachromosomal DNA in cutaneous squamous cell carcinoma is associated with increased nodal disease
6. 806 Immune related gene expression analysis of de novo primary skin cancers in patients receiving immune checkpoint inhibitors for advanced cSCC
7. A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors
8. AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer – results of two parallel first-in-human phase I studies
9. Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1
10. Equitable Utilisation of Indian Community Based Health Insurance Scheme among Its Rural Membership: Cluster Randomised Controlled Trial
11. Barriers to accessing benefits in a community-based insurance scheme: lessons learnt from SEWA Insurance, Gujarat
12. CRTs – Cluster Randomized Trials or "Courting Real Troubles": Challenges of Running a CRT in Rural Gujarat, India
13. Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding study
14. Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours
15. Promoting health equity in conflict-affected fragile states
16. Intervention complexity: a conceptual framework to inform priority-setting in health
17. Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies
18. Quality of hysterectomy care in rural Gujarat: the role of community-based health insurance
19. Optimisation of circulating biomarkers of cell death for routine clinical use
20. Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours
21. A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva®, OSI-774) in patients with advanced solid tumors of epithelial origin
22. Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma
23. Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial
24. Protecting the poor? the distributional impact of a bundled insurance scheme
25. Measuring improved targeting of health interventions to the poor in the context of a community-randomised trial in rural India
26. Un bloc nerveux régional permet d'optimiser la technique de création d'un accès artério-veineux pour hémodialyse en améliorant la dilatation veineuse superficielle
27. Making health insurance work for the poor: Learning from the Self-Employed Women's Association's (SEWA) community-based health insurance scheme in India
28. Assessment of diurnal changes and confounding factors that affect circulating cell death biomarker levels: A short communication☆,☆☆
29. In Vitro Cytotoxicity of Bismuth-213 (213bi)-Labeled-Plasminogen Activator Inhibitor Type 2 (Alpha-PAI-2) on Human Breast Cancer Cells
30. Making health insurance work for the poor: Learning from the Self-Employed Women's Association's (SEWA) community-based health insurance scheme in India
31. Learning from toxicity patterns in phase I trials during the era of mechanism targeted agents
32. IN VIVO PHARMACOKINETICS OF RADIOIODINATED UROKINASE PLASMINOGEN ACTIVATOR (UPA) INHIBITORS FOR IMAGING METASTATIC CANCER: O30
33. Human plasminogen and Group A Streptococcal M-like protein: interaction, conformational transition and activation: O9–04
34. Biomarker method validation in anticancer drug development
35. Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer
36. The global burden of trachomatous visual impairment: I. Assessing prevalence
37. The global burden of trachomatous visual impairment: II. assessing burden
38. Apoptosis as a drug target: O.502 INHIBITORS OF APOPTOSIS INHIBITORS
39. Gefitinib, a novel, orally administered agent for the treatment of cancer
40. Randomized Phase II Study of Temozolomide Given Every 8 Hours or Daily With Either Interferon Alfa-2b or Thalidomide in Metastatic Malignant Melanoma
41. Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor Types
42. Estimates of Global and Regional Smoking Prevalence in 1995, by Age and Sex
43. Phase II study of exatecan mesylate (DX-8951f) as first line therapy for advanced non-small cell lung cancer
44. Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesothelioma
45. A scoping review about conference objectives and evaluative practices: how do we get more out of them?
46. Quality of Hysterectomy Care in Rural Gujarat: The Role of Community-Based Health Insurance
47. Cost effectiveness and cost utility of preventing trachomatous visual impairment: lessons from 30 years of trachoma control in Burma
48. Conformational rearrangements of plasminogen activator inhibitor type 2
49. Targeting the urokinase plasminogen activator (uPA) pathway inhibits pancreatic cancer progression
50. SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.